These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21272687)

  • 1. Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullary thyroid carcinoma.
    Biermann K; Biersack HJ; Sabet A; Janzen V
    Semin Nucl Med; 2011 Mar; 41(2):139-48. PubMed ID: 21272687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.
    Sarlis NJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of thyroid cancer.
    Sherman SI
    Biochem Pharmacol; 2010 Sep; 80(5):592-601. PubMed ID: 20471374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New targets and therapeutic approaches for endocrine malignancies.
    Fassnacht M; Kreissl MC; Weismann D; Allolio B
    Pharmacol Ther; 2009 Jul; 123(1):117-41. PubMed ID: 19374919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of undifferentiated thyroid cancer.
    Ain KB
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):615-29. PubMed ID: 11289738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular targeted therapies in thyroid cancer.
    Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
    Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy and gene therapy of thyroid cancer.
    Schott M; Scherbaum WA
    Minerva Endocrinol; 2004 Dec; 29(4):175-87. PubMed ID: 15765027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy in thyroid cancer.
    Nixon IJ; Shaha AR; Tuttle MR
    Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):130-4. PubMed ID: 23435040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
    Pfragner R; Skofitsch G; Höger H; Jech M; Rinner B; Siegl V; Niederle B; Gnant M; Friedl J; Stift A
    Anticancer Res; 2005; 25(6B):4225-30. PubMed ID: 16309220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of invasive and advanced thyroid cancer.
    Favia G; Iacobone M; Zanella S; Ciarleglio FA
    Minerva Endocrinol; 2009 Mar; 34(1):37-55. PubMed ID: 19209127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide].
    Frank-Raue K; Raue F; Ziegler R
    Med Klin (Munich); 1995 Feb; 90(2):63-6. PubMed ID: 7708002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliation of advanced thyroid malignancies.
    Greenblatt DY; Chen H
    Surg Oncol; 2007 Dec; 16(4):237-47. PubMed ID: 17855077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on recent developments in the therapy of differentiated thyroid cancer.
    Middendorp M; Grünwald F
    Semin Nucl Med; 2010 Mar; 40(2):145-52. PubMed ID: 20113682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.